VIR - Vir Biotechnology - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

VIR is currently covered by 9 analysts with an average price target of $19. This is a potential upside of $9.51 (100.21%) from yesterday's end of day stock price of $9.49.

Vir Biotechnology's activity chart (see below) currently has 55 price targets and 61 ratings on display. The stock rating distribution of VIR is 65.38% BUY, 11.54% SELL and 23.08% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.91% with an average time for these price targets to be met of 141.54 days.

Highest price target for VIR is $41, Lowest price target is $10, average price target is $19.

Most recent stock forecast was given by ERIC JOSEPH from JPMORGAN on 23-Feb-2024. First documented stock forecast 05-Nov-2019.

Currently out of the existing stock ratings of VIR, 17 are a BUY (65.38%), 3 are a SELL (11.54%), 6 are a HOLD (23.08%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

10

$0.51 (5.37%)

9

1 months 20 days ago

2/4 (50%)

$-1.53 (-13.27%)

15

Buy

1 months 29 days ago

1/7 (14.29%)

$76.91 (333.09%)

128

12

$2.51 (26.45%)

15

5 months 6 days ago

1/3 (33.33%)

$3.37 (39.05%)

3

Buy

15

$5.51 (58.06%)

22

5 months 9 days ago

0/9 (0%)

$6.24 (71.23%)

Hold

14

$4.51 (47.52%)

55

7 months 4 days ago

1/2 (50%)

$3 (27.27%)

113

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VIR (Vir Biotechnology) average time for price targets to be met?

On average it took 141.54 days on average for the stock forecasts to be realized with a an average price target met ratio 54.91

Which analyst has the current highest performing score on VIR (Vir Biotechnology) with a proven track record?

ANUPAM RAMA

Which analyst has the most public recommendations on VIR (Vir Biotechnology)?

Anupam Rama works at JPMORGAN and has 18 price targets and 10 ratings on VIR

Which analyst is the currently most bullish on VIR (Vir Biotechnology)?

Alan Carr with highest potential upside - $33.74

Which analyst is the currently most reserved on VIR (Vir Biotechnology)?

Patrick Trucchio with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?